Notice of Retraction Oxidative Damage of Fe3O4 Nanoparticles on Mouse Hepatic Cells In Vitro

ye yuan,jiaqi tang,chenxi wei,bing han,xu yang
DOI: https://doi.org/10.1109/icbbe.2011.5781375
2011-01-01
Abstract:Notice of Retraction After careful and considered review of the content of this paper by a duly constituted expert committee, this paper has been found to be in violation of IEEE's Publication Principles. We hereby retract the content of this paper. Reasonable effort should be made to remove all past references to this paper. The presenting author of this paper has the option to appeal this decision by contacting TPII@ieee.org. Abstract-In order to assess the biological safety of Fe3O4 nanoparticles, oxidative damage of which was studied. Mouse hepatic cells were exposed to different dose (50 μg/mL, 100 μg/mL, 200 μg/mL, 400 μg/mL) of Fe3O4 nanoparticles in vitro for 1 hour. Methods of 2, 7-dichlorohydrofluoroscein diacetate (DCFH-DA), 5, 5'-dithiobis (2-nitrobenzoic acid) (DTNB), thiobarbituric acid (TBA) were used to detect reactive oxygen species (ROS) level, glutathione (GSH) and malondialdehyde (MDA) content, respectively. The levels of ROS were all increased in exposure groups, especially in the group of 200 μg/mL (p<;0.05) and 400 μg/mL (p<;0.01). GSH content presented a slight increase compared with the control group but no significant difference in the dose of 50 μg/mL. Then GSH content began to decrease. When the concentration of Fe3O4 nanoparticles increased to 200 μg/mL, there was a significant difference compared with the control group (p<;0.05). However, the MDA concentration in hepatic cells showed a dose-dependent decrease after Fe3O4 nanoparticles exposure (p<;0.05, p<;0.01). These results suggested that Fe3O4 nanoparticles could cause oxidative damage on mouse liver in vitro, and might have toxic effects on human body under high concentration (>;200 μg/mL).
What problem does this paper attempt to address?